This narrative review (RodrΓguez & Burgos, medical students, Universidad Mayor de San SimΓ³n, Bolivia; Rev Peru Cienc Salud 2024;6(1):58-65) screened 4,439 records but included only 21 articles (2004β2024, English/Spanish) from SciELO, PubMed, UNAL, and Frontiers, categorizing Pseudomonas aeruginosa resistance as intrinsic, acquired, and adaptive. It correctly reports the canonical mechanisms: low outer-membrane permeability, RND efflux pumps (three-component architecture), porin alterations, chromosomal AmpC, ESBL/carbapenemase acquisition via mobile genetic elements, biofilm matrix tolerance, and quorum-sensing regulation of virulence .
An independent quantitative dataset supports the review's permeability/Ξ²-lactamase emphasis: across 30 clinical strains, cephazolin showed only 18.75% outer-membrane permeability with 100% resistance, while more permeable drugs (piperacillin 53.12%) had lower resistance, confirming that permeability plus Ξ²-lactamase productionβnot penicillin-binding-protein affinityβdrive Ξ²-lactam resistance .
Efflux pumps: a Nanning (China) study of 81 MDR-PA isolates found NDM-1 in 34.57% (28/81), elevated MexA efflux-pump expression (2.47Β±2.30 vs 0.97Β±0.47 in sensitive strains), and predominance of clone ST1971 β empirically substantiating the review's efflux and MGE claims . Biofilm tolerance: the review's PA3177/c-di-GMP claim aligns with biofilm-specific resistance genes; ndvB regulates ethanol-oxidation genes whose inactivation increases tobramycin sensitivity in PA14 biofilms , and BatR (PA3049) emerged as a newer regulator the review could not cover . QS interference: a molecularly imprinted polymer sequestering the QS signal reduced biofilm formation >80% vs 40% (blank), Kd 145Β±2 ΞΌM vs 312Β±3 ΞΌM, empirically supporting the review's quorum-sensing section .
Strengths: accurate tripartite classification, historical context, correct prioritization per WHO critical pathogen list, honest limitations statement (selection bias, variable source quality, database access bias). Weaknesses: narrative (not systematic) design without PRISMA registration, dual-protocol searches or risk-of-bias assessment; conspicuous numerology errors (the PRISMA figure claims "N = 4,439" but the listed databases sum to ~6,065, an internal inconsistency); several malformed references (e.g., citation 10 erroneously carries the paper's own DOI); no quantitative synthesis, tables of mechanismβgeneβdrug mapping, or critical appraisal of included evidence; adaptive-resistance section omits well-established adaptive mechanisms (swarming-associated tolerance, persister cells) documented in the field . The authors are medical students; the work is a competent but non-original educational synthesis. Confidence: moderateβconclusions are consensus-level and unlikely wrong, but no new data or analysis is contributed.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.